Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project - Trial NCT06351228
Access comprehensive clinical trial information for NCT06351228 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano and is currently Not yet recruiting. The study focuses on Cervical Cancer. Target enrollment is 400 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Timeline & Enrollment
N/A
Mar 30, 2024
Dec 31, 2024
Primary Outcome
oncological outcomes
Summary
The ETERNITY project is a retrospective analysis of outcomes of patients undergoing
 fertility-sparing treatment for cervcial cancer.
 
 The primary aim is to report outcomes of those patients.
 
 Other aims included:
 
 1. Evaluation about the effectiveness of different treatment modalities;
 
 2. Evaluation of outcomes according to different stages of disease;
 
 3. Evaluation of the impactof neoadjuvant chemotherapy in patients undergoing conservative
 surgery
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06351228
Non-Device Trial